![]() ![]() Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. The median estimate represents a 9.72% increase from the last price of 0.91.According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. On May 11, 2023, ViewRay Inc’s stock (VRAY) had a median target price of 1.00, with a high estimate of 2.00 and a low estimate of 1.00, according to data from CNN Money. ViewRay Incs Stock (VRAY) Median Target Price Predicts 9.72% Increase by 2023 ![]() The company had an annual revenue of $102.2M in the previous year, but had a net loss of -$107.3M, with a net profit margin of -105.01%. The next reporting date for VRAY is on August 3, 2023, with an EPS forecast for this quarter of -$0.15. ![]() VRAY operates in the health technology sector and medical specialties industry, and is headquartered in Oakwood Village, Ohio. VRAY had a positive earnings growth rate of 11.20% in the previous year and a growth rate of 2.33% in the current year, but there is no available data on the projected earnings growth rate for the next five years. The volume of shares traded on this day was 41,616, significantly lower than the average volume of shares traded over the past three months, which is 2,641,375. On May 11, 2023, VRAY stock opened at 0.86, down from the previous day’s close of 1.01, and fluctuated within a range of 0.85 to 0.92. VRAY Stock Opens Lower on with Lower Trading Volume and Positive Earnings Growth Rate Prior to the downgrade, ViewRay had two buy ratings, five hold ratings, and no sell ratings. On the same date, the company’s shares closed at $1.00. This is based on a range of forecasts, with the lowest being $1.26 and the highest being $4.20. ![]() This change came as a result of a more cautious and conservative outlook for the year 2023.Īs of May 11, 2023, the average one-year price target for ViewRay is $2.55. He also lowered the price target from $4 to $1. Riley Securities analyst Justin Walsh made the decision to downgrade ViewRay (NASDAQ: VRAY) from Buy to Neutral. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |